Resistance to doxorubicin (Dxr) or cyclophosphamide in myr-AKT activated or PTEN+/−Eμ-Myc lymphomas has been linked to (a) defective apoptotic program(s) dependent on increased mTOR activity and linked to elevated translation initiation rates. This evidence concerns the gene MTOR and lymphoma.